Corporate ActionMay 5, 2026, 04:23 PM
Biohaven Authorizes $350M At-The-Market Equity Offering
AI Summary
Biohaven Ltd. has amended its Equity Distribution Agreement, allowing the company to sell up to an aggregate offering price of $350.0 million of its common shares through an "at-the-market" equity offering program. J.P. Morgan Securities LLC will serve as the manager for these sales, which may occur on the New York Stock Exchange or through negotiated transactions. The actual sales will depend on market conditions, the trading price of common shares, and the company's capital needs.
Key Highlights
- Biohaven Ltd. entered Amendment No. 2 to its Equity Distribution Agreement.
- The company may sell up to $350.0 million of common shares.
- Sales will be conducted through an "at-the-market" equity offering program.
- J.P. Morgan Securities LLC will act as the manager for the offering.
- The offering is pursuant to an effective shelf registration statement filed May 4, 2026.